Mr. Richie O Yu, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 4811 N Olcott Ave Unit 609, Harwood Heights, IL 60706 Phone: 773-780-7656 |
News Archive
Neurologix has announced positive interim results of its landmark gene therapy clinical trial for patients with Parkinson's disease. Neurologix's 12-patient, dose-escalating Phase I trial is the world's first study to use a viral vector (the non-pathogenic adeno-associated virus, or AAV) for the treatment of an adult neurological disease.
Individuals with defects in copper metabolism may soon have more targeted treatment options thanks to a discovery by a research team led by Dr. Vishal Gohil of Texas A&M AgriLife Research in College Station.
When Alfred Williams was admitted to Ochsner Medical Center in December, the 41-year-old father of five had exhausted all treatment options for his enlarged heart. His condition, known as dilated cardiomyopathy, had progressed to end-stage heart failure affecting both sides of his heart. Unable to walk, he had been confined to a bed for months. Hospice care seemed like the only option Mr. Williams had left… until doctors approached him about becoming Ochsner's first patient to receive the SynCardia temporary Total Artificial Heart.
In the state of Texas, 59 percent of our child care operations are located in home-based environments, yet state and local quality improvement programs often overlook this important group. The Children's Learning Institute at The University of Texas Health Science Center at Houston (UTHealth), in partnership with Gov. Rick Perry's Texas Early Learning Council, has taken a step forward in addressing the quality of these operations by offering free training for up to 300 home-based child care providers in the state.
› Verified 3 days ago